Cite
APA Citation
Watanabe, T., Tobinai, K., Matsumoto, M., Suzuki, K., Sunami, K., Ishida, T., Ando, K., Chou, T., Ozaki, S., Taniwaki, M., Uike, N., Shibayama, H., Hatake, K., Izutsu, K., Ishikawa, T., Shumiya, Y., Kashihara, T., & Iida, S. (2016). a phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma. British journal of haematology, 172, 745–756. http://access.bl.uk/ark:/81055/vdc_100030761553.0x000053